Application of brown planthopper gene NlFAD9 in prevention and treatment of brown planthopper
By using the brown planthopper gene NlFAD9 as a target, combining RNA interference technology, dsRNA is designed and injected into brown planthopper nymphs, the problem of poor prevention and treatment of brown planthoppers in the existing technology is solved, significantly reducing its survival rate and molting success rate, providing An effective biological control method is established.
Patent Information
- Application Number
- CN202411471878.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-22
- Publication Date
- 2024-11-19
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
There is a lack of effective target genes for brown planthopper prevention and control in the prior art, and the existing RNAi technology has limited effect on brown planthopper prevention and control, making it difficult to significantly reduce its survival rate and molt success rate.
By extracting and using the brown planthopper gene NlFAD9 as a target, combining RNA interference technology, the corresponding dsRNA is designed and synthesized, and the brown planthopper nymphs are injected to inhibit the expression of the NlFAD9 gene and reduce its survival rate and molting success rate.
It significantly reduces the survival rate and molting success rate of brown planthoppers, provides an effective biological control method, and has good application prospects.
Smart Images

Figure CN118979042A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biological control, and specifically relates to application of a brown planthopper gene N1FAD9 in the control of brown planthopper. Background Art
[0002] Brown Planthopper Nllaparvatalugens (Stål) is a typical monophagous piercing-sucking insect that feeds on rice. It is characterized by its explosiveness, destructiveness, and long-distance migration. It is very easy to cause disasters and is one of the most serious insects that harm rice.
[0003] RNA interference (RNAi) mainly refers to the phenomenon of highly conserved, highly efficient and specific degradation of homologous mRNA induced by double-stranded RNA (dsRNA) during evolution. RNAi technology plays an important role in studying insect growth and development and related gene functions. By introducing exogenous double-stranded RNA of specific genes into insects, endogenous target mRNA degradation can be caused, resulting in target gene silencing or downregulation of expression.
[0004] At present, RNAi technology has been widely used in the field of agricultural science and technology, including but not limited to crop improvement, biological control, and insect resistance functional gene research.
[0005] In the prior art, interference tests on insects by RNAi have been reported in Hemiptera, Hymenoptera, Lepidoptera, Orthoptera and Coleoptera. RNAi technology has also been used in the prevention and control of brown planthoppers. For example, Chinese patent application number CN116947998A discloses the use of the brown planthopper PEX16 gene as a target in the prevention and control of brown planthoppers. By inhibiting the PEX16 gene, the survival time of female brown planthoppers and the number of eggs laid can be reduced, thereby achieving the purpose of preventing and controlling brown planthoppers.
[0006] In order to reduce the harm caused by brown planthoppers, it is urgent to find a target gene that can effectively control brown planthoppers, and to further develop biological control methods that can effectively control brown planthopper populations based on the target gene. Summary of the invention
[0007] In order to develop a biological control method that can effectively reduce the damage of brown planthoppers, the present invention studies the effect of the brown planthopper gene NlFAD9 on the survival rate and molting of brown planthoppers. The results show that the NlFAD9 gene has application potential in controlling brown planthoppers. The present invention uses the brown planthopper gene NlFAD9 as a target and provides a dsRNA biological control application targeting brown planthoppers based on RNAi technology.
[0008] In one aspect, the present invention provides an application of the brown planthopper gene NlFAD9 in the control of brown planthoppers, wherein the nucleotide sequence of the NlFAD9 gene is shown in SEQ ID NO.1.
[0009] RNA interference technology (RNAi) specifically includes the following steps: 1) PCR amplification using NlFAD9 gene as template; 2) Connect the NlFAD9 gene amplified in step 1) to the pMD19-T vector and transform it into DH5α competent cells; culture the transformed DH5α Escherichia coli; 3) extracting the plasmid from the DH5α Escherichia coli culture obtained in step 2), and amplifying it with amplification primers containing a T7 promoter sequence to obtain T7-NlFAD9; and then synthesizing dsNlFAD9 using T7-NlFAD9 as a template; 4) Injection of dsRNA into brown planthopper nymphs.
[0010] Preferably, the PCR amplification primers in step 1) are the front primer NlFAD9-F and the rear primer NlFAD9-R; The sequence of NlFAD9-F is shown in SEQ ID NO.2; The sequence of NlFAD9-R is shown in SEQ ID NO.3.
[0011] Preferably, the amplification primers containing the T7 promoter sequence in step 3) are T7-NlFAD9-F and T7-NlFAD9-R;
[0012] The sequence of T7-N1FAD9-F is shown in SEQ ID NO.4; The sequence of T7-N1FAD9-R is shown in SEQ ID NO.5; The sequence of the T7-NlFAD9 is shown in SEQ ID NO.6.
[0013] Preferably, the dsNlFAD9 sequence synthesized in step 3) is as shown in SEQ ID NO.7.
[0014] Another aspect of the present invention provides a use of a brown planthopper gene NlFAD9 as a target in the preparation of a brown planthopper control drug, wherein the nucleotide sequence of the NlFAD9 is shown in SEQ ID NO.1.
[0015] Preferably, the drug is a drug prepared using the dsRNA positive strand of the N1FAD9 gene of the brown planthopper.
[0016] Preferably, the nucleotide sequence of the dsRNA positive strand of the NlFAD9 gene is as shown in SEQ ID NO.7.
[0017] Another aspect of the present invention provides a dsRNA for controlling brown planthopper, the nucleotide sequence of which is shown in SEQ ID NO.7.
[0018] Compared with the prior art, the present invention has the following technical effects: The present invention extracts the NlFAD9 gene from the brown planthopper genome, and the nucleotide sequence of the NlFAD9 gene is shown in SEQ ID NO. 1. There is no related research on pest control using the NlFAD9 gene as a target in the prior art, and the biological phenotype caused by the gene defect is also unclear.
[0019] The present invention utilizes RNAi technology to significantly reduce the survival rate of brown planthoppers by inhibiting the expression level of NlFAD9 gene, thereby achieving the control of brown planthoppers. Studies have found that the NlFAD9 gene of brown planthoppers can be used as a target to prepare drugs that inhibit the survival of brown planthoppers.
[0020] The invention provides an effective target site and control strategy for brown planthopper control and has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 This is a graph analyzing the expression level of the N1FAD9 gene in Example 3 of the present invention; Figure 2 The survival rate statistics of brown planthopper after RNAi in Example 3 of the present invention; Figure 3 , Figure 4 The phenomenon of death during molting after the N1FAD9 gene of the brown planthopper is disturbed in Example 3 of the present invention; wherein Figure 3 The brown planthopper died because it failed to molt successfully. Figure 4 The brown planthopper died during the molting process. DETAILED DESCRIPTION
[0022] In order to further understand the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below in combination with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments.
[0023] In the example of the present invention, the nucleotide sequence of the NlFAD9 gene of the brown planthopper is shown as SEQ ID NO.1; the dsRNA targeting the NlFAD9 gene of the brown planthopper, that is, the nucleotide sequence of the positive strand of the dsNlFAD9 gene is shown as SEQ ID NO.7.
[0024] Example 1. Cloning of the N1FAD9 gene of the brown planthopper The nucleotide sequence of the NlFAD9 gene of the brown planthopper is shown in SEQ ID NO. 1. Primers were designed using Primer Premier 6.0 to obtain the front primer NlFAD9-F and the rear primer NlFAD9-R.
[0025] The sequence of NlFAD9-F is shown in SEQ ID NO.2; The sequence of NlFAD9-R is shown in SEQ ID NO.3.
[0026] (1) PCR amplification using brown planthopper cDNA as template: The PCR amplification system (50 μL) was: EX taq 25 μL, ddH2O 19 μL, NlFAD9-F (10 μM) 2 μL, NlFAD9-R (10 μM) 2 μL, and brown planthopper cDNA (200 ng / μL) 2 μL.
[0027] Add all PCR reaction reagents into a 1.5 ml centrifuge tube, put it into the PCR instrument, and set the conditions as follows: pre-denaturation: 95°C, 3 min, one cycle; denaturation: 95°C, 30 s; annealing: temperature is the TM value of the primer -5°C, 30 s, number of cycles is 30-35 times; extension: 72°C, 30 s, one cycle.
[0028] After amplification, electrophoresis was performed for verification, and the gel was harvested using the SanPrep column DNA gel recovery kit (Sangon Biotech) to obtain 25 μL of amplified product with a concentration of 152.6 ng / μL.
[0029] (2) Connect the amplified product to the vector The amplified product was ligated with pMD-19T (vector) to obtain a ligation product.
[0030] Reaction system (pMD19-T Vector Cloning Kit (TaKaRa), 10μL): pMDTM19-T 1μL, gel recovery product (concentration 152.6ng / μL) 3μL, ddH2O 1μL, Solution Ⅰ 5μL; reaction conditions: overnight reaction at 16℃.
[0031] (3) Conversion Take out DH5α cells (E.coli DH5α Competent Cells, Solarbio) from the -80℃ refrigerator, freeze and thaw on ice, add 10μL of the ligation product to 50μL of competent cells, flick 10 times, put in ice bath for 30min, heat shock at 42℃ for 2min, and then put in ice bath for 3min, and transfer to the clean bench. Add 800μL of LB medium without ampicillin, shake at 37℃ for 45min-1h, aspirate the supernatant and leave about 200ul, blow and mix, add to the LB solid medium plate with ampicillin, and spread it evenly with a triangular glass rod. Put it upright for 30min. In a 37℃ constant temperature incubator, put the coated plate upside down, and check it after overnight culture for 12-14h. If plaques grow, pick out a single colony with a gun tip under the clean bench and put it into a 1.5ml centrifuge tube containing 1ml LB liquid medium (containing 1μL ampicillin) for bacterial liquid expansion and shake, and leave it overnight. Take out 100 μL of the amplified bacterial solution in the clean bench for PCR verification. If the PCR verification band result of the bacterial solution is correct, divide the corresponding bacterial solution into 500 μL in the clean bench for sequencing. The sequencing results show that the ligation product contains the NlFAD9 gene, indicating that the ligation product was successfully prepared and named pMD19T-NlFAD9.
[0032] Example 2. Synthesis of dsRNA The T7 promoter sequence TAATACGACTCACTATAGGGAGA was added to the front end of the 5' end of the sequences of the front primer NlFAD9-F and the rear primer NlFAD9-R designed in Example 1 to obtain two pairs of primers T7-NlFAD9-F and T7-NlFAD9-R, respectively.
[0033] The sequence of T7-N1FAD9-F is shown in SEQ ID NO.4; The sequence of T7-NlFAD9-R is shown in SEQ ID NO.5.
[0034] (1) Extraction and concentration determination of bacterial plasmids (a) Place the required materials (1000 μL pipette and pipette tip, sterilized 1.5 mL centrifuge tube) in a clean bench and irradiate with UV light for 30-45 min. Place the culture solution prepared in step (3) of Example 1 in a 37°C shaker for about 1 h. Aliquot the culture solution in a clean bench, with each 1 mL of the culture solution being dispensed into one 1.5 mL centrifuge tube, for a total of three tubes. Take out the aliquoted culture solution and place it on ice.
[0035] (b) Plasmid extraction was performed using the SanPrep Column Plasmid DNA Miniprep Kit (Sangon Biotech). The bacterial solution was centrifuged at 8000 rpm for 2 min. The supernatant was removed, leaving only the precipitate. 250 μL of Buffer P1 was added to the precipitate, so that all the three tubes of precipitate were dissolved in 250 μL of Buffer P1. Then 250 μL of Buffer P2 was added, and the centrifuge tubes were immediately and gently inverted 10 times to mix. The tubes were allowed to stand at room temperature for 4 min. Then 350 μL of Buffer P3 was added, and the centrifuge tubes were immediately and gently inverted 10 times to mix. The tubes were placed in a centrifuge at 11000 rpm for 10 min, and the supernatant was transferred to the adsorption column. The tubes were then centrifuged at 9000 rpm for 30 s, and the filtrate was discarded. Then 500 μL of Buffer DW1 was added to the adsorption column, and the tubes were centrifuged at 9000 rpm for 30 s. The filtrate was discarded. Then 500 μL of Wash Solution was added, and the tubes were centrifuged at 9000 rpm for 30 s. The filtrate was discarded. Repeat the Wash Solution operation, centrifuge the empty adsorption column at 9000rpm for 1min, add 75μL of 60℃ RNA-free water to the center of the adsorption membrane, and centrifuge at 9000rpm for 1min to obtain a solution containing plasmid. The plasmid concentration was measured, and the measurement results showed that the concentration was 216.3ng / μL.
[0036] (2) Gene cloning containing T7 promoter sequence PCR reaction system: LA taq 25.0μL, ddH2O 19.0μL, T7-NlFAD9-F (10μM) 2.0μL, T7-NlFAD9-R (10μM) 2.0μL, plasmid extracted in Example 2 (b) (216.3ng / μL) 2.0μL. After the premix is prepared and aliquoted, it is placed in a PCR instrument, pre-annealed once at 95℃ for 3min, annealed at the same temperature for 30s, then annealed 34 times at TM-5℃ for 30s, and extended at 72℃ for 1min and 5min. After the PCR is completed, electrophoresis verification is performed, that is, electrophoresis is performed in a 1% concentration agarose gel and recovered. The target band is cut out and placed in a centrifuge tube, and the gel block is weighed. Add 300 μL of Buffer B2 solution for every 100 mg, and heat the centrifuge tube in a 50°C water bath until the gel block is completely melted. Transfer all the solution into the adsorption column, centrifuge at 8000rpm for 30s, and discard the filtrate; add 300 μL of Buffer B2 solution, centrifuge at 9000rpm for 30s, and discard the filtrate; add 500 μL of Wash Solution, centrifuge at 9000rpm for 30s, and discard the filtrate. Add 25 μL of 60°C RNA-free water to the center of the adsorption membrane, centrifuge at 9000rpm for 1min, and recover the NlFAD9 gene containing the T7 promoter, named T7-NlFAD9, and the sequence is shown in SEQ ID NO.6. The product concentration is 156.7 ng / μL.
[0037] (3) Synthetic dsRNA The dsRNA was synthesized according to the instructions of the MEGA script® Kit, and the reaction system is shown in Table 1. After the reaction solution was prepared according to the system, the PCR instrument was incubated at 37°C for 16 hours. After the incubation was completed, 1 μL of TURB DNase solution was added to remove the incompletely reacted cDNA template. Under the same conditions, the PCR instrument was reacted at 37°C for 15 minutes to obtain the dsRNA: dsNlFAD9, whose sequence is shown in SEQ ID NO.7.
[0038] Table 1 dsRNA synthesis system Reagents Usage T7-NlFAD9 8μL ATP solution 2μL UTP solution 2μL GTP solution 2μL CTP solution 2μL 10×Reaction Buffer 2μL Enzyme Mix 2μL Example 3. dsRNA microinjection and interference efficiency detection The fourth-instar (4d) brown planthopper nymphs were selected for dsRNA injection. dsNlFAD9 was set as the experimental group, and the GFP gene was set as the control group. Three replicates were set up in each group, and 100 brown planthoppers were injected in each replicate (i.e., 300 were injected for each gene). The injected brown planthoppers were placed in a transparent plastic jar with rice seedlings and raised in an artificial climate room. The survival rate of the brown planthoppers was counted every day. The phenotypic changes were observed.
[0039] Fluorescence quantitative PCR detection of interference efficiency: The brown planthoppers that survived 72 hours after injection of dsRNA were collected. 6-8 insects were collected in each group, and 3 replicates were collected for each gene. The collected insects were subjected to RNA extraction and cDNA synthesis. This cDNA was used as a template for RT-qPCR experiments, and compared with the control group GFP group to determine the interference efficiency. Fluorescence quantitative PCR primers were designed, and the sequence of the upper primer q-NlFAD9-F was shown in SEQ ID NO.8, and the sequence of the lower primer q-NlFAD9-R was shown in SEQ ID NO.9.
[0040] Depend on Figure 1 It can be seen that the corresponding NlFAD gene expression levels in the treatment group were significantly different from those in the control group GFP group, and both showed a significant decrease in expression level. (RT-qPCR technology and △△Ct method were used to analyze the expression levels of the relevant FAD genes in the experimental group and the GFP control group. Each group had three biological replicates, and the results were displayed together with the standard deviation. One-way ANOVA was used for statistical analysis. ***, p<0.001; ****, p<0.0001) Statistics of survival rate of brown planthopper after disturbance Within 10 days after injection, dead brown planthoppers were removed for phenotypic observation, the number of deaths was recorded every day, and the survival rate of brown planthoppers was counted every day.
[0041] from Figure 2 The survival rate of the dsNlFAD9 treatment group was 35%, and the survival rate of the dsGFP control group was 93.33%. The survival rate of the dsNlFAD9 treatment group was significantly lower than that of the dsGFP group. The experimental results showed that when the expression level of the NlFAD9 gene was significantly reduced after interference, the survival rate of the brown planthopper decreased significantly, further indicating that the purpose of controlling the brown planthopper can be achieved by inhibiting the expression level of the NlFAD9 gene.
[0042] Observation of the phenotypic changes of brown planthopper after disturbance: Figure 3 , Figure 4 It can be seen that after the NlFAD9 gene was interfered, the brown planthopper had a phenotype of molting and death after RNAi. Figure 3 The brown planthopper died because it failed to molt successfully. Figure 4 The brown planthopper died during the molting process.
[0043] Unless otherwise specified, the raw materials and equipment used in the present invention are all commonly used materials and equipment in the art; the methods used in the present invention are all conventional methods in the art unless otherwise specified.
[0044] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any way. Any simple modification, change and equivalent transformation made to the above embodiment based on the technical essence of the present invention still falls within the protection scope of the technical solution of the present invention.
[0045] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For the technical personnel in this field, the present invention can have various changes and variations. Any modification, equivalent replacement, improvement, etc. made to the present invention should be included in the protection scope of the present invention.
Claims
1. An application of a brown planthopper gene N1FAD9 in the control of brown planthoppers, characterized in that: The nucleotide sequence of the NlFAD9 gene is shown in SEQ ID NO.
1.
2. The use according to claim 1, characterized in that The method for controlling brown planthoppers is RNA interference technology.
3. The use according to claim 2, characterized in that RNA interference specifically includes the following steps: 1) PCR amplification using NlFAD9 gene as template; 2) Connect the NlFAD9 gene amplified in step 1) to the pMD19-T vector and transform it into DH5α competent cells; culture the transformed DH5α Escherichia coli; 3) extracting the plasmid from the DH5α Escherichia coli culture obtained in step 2), and amplifying it with amplification primers containing a T7 promoter sequence to obtain T7-NlFAD9; and then synthesizing dsNlFAD9 using T7-NlFAD9 as a template; 4) Injection of dsRNA into brown planthopper nymphs.
4. The use according to claim 3, characterized in that: The PCR amplification primers in step 1) are the front primer NlFAD9-F and the rear primer NlFAD9-R; The sequence of NlFAD9-F is shown in SEQ ID NO.2; The sequence of NlFAD9-R is shown in SEQ ID NO.
3.
5. The use according to claim 3, characterized in that: The amplification primers containing the T7 promoter sequence in step 3) are T7-NlFAD9-F and T7-NlFAD9-R; The sequence of T7-N1FAD9-F is shown in SEQ ID NO.4; The sequence of T7-N1FAD9-R is shown in SEQ ID NO.5; The sequence of the T7-NlFAD9 is shown in SEQ ID NO.
6.
6. The use according to claim 3, characterized in that: The dsNlFAD9 sequence synthesized in step 3) is shown as SEQ ID NO.
7.
7. A use of the brown planthopper gene N1FAD9 as a target in the preparation of a drug for controlling brown planthoppers, characterized in that: The nucleotide sequence of the NlFAD9 is shown in SEQ ID NO.
1.
8. The use according to claim 7, characterized in that The medicine is a medicine prepared by using the dsRNA positive strand of the N1FAD9 gene of the brown planthopper.
9. The use according to claim 8, characterized in that The nucleotide sequence of the dsRNA positive strand of the NlFAD9 gene is shown in SEQ ID NO.
7.
10. A dsRNA for controlling brown planthopper, characterized in that: The nucleotide sequence is shown in SEQ ID NO.7.
Citation Information
Patent Citations
Control of pests in plants
CN102648283A
Application of nilaparvata lugens E3 ubiquitin ligase gene NlHECTD2 as target spot in preparation of medicine for preventing and treating nilaparvata lugens
CN116103294A
Brown planthopper PEX16 gene and application of protein coded by brown planthopper PEX16 gene in prevention and treatment of brown planthopper
CN116947998A
Genetic control method and compositions against insect pests in cotton plants by the silencing of genes of the laccase family
US20150368649A1
